Versant Capital Management, Inc 10x Genomics, Inc. Transaction History
Versant Capital Management, Inc
- $578 Million
- Q1 2025
A detailed history of Versant Capital Management, Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 12,082 shares of TXG stock, worth $105,475. This represents 0.02% of its overall portfolio holdings.
Number of Shares
12,082
Previous 282
4184.4%
Holding current value
$105,475
Previous $4,000
2525.0%
% of portfolio
0.02%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TXG
# of Institutions
303Shares Held
96.2MCall Options Held
76.4KPut Options Held
132K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$104 Million1.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$95.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$55.8 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.5.71MShares$49.9 Million0.92% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.71MShares$49.9 Million0.06% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $830M
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...